✦ LIBER ✦

Thrombin-independent mechanisms for direct thrombin inhibitor reduction of intimal hyperplasia

✍ Scribed by L. Mureebe; D. Silver

Book ID: 116701566
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 47 KB
Volume: 121
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2004.07.120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of Intimal Hyperplasia by Dir

Inhibition of Intimal Hyperplasia by Direct Thrombin Inhibitors in an Animal Vein Bypass Model

✍ Leila Mureebe; Susan E. Turnquist; Donald Silver 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 96 KB

Antithrombin-independent thrombin inhibi

Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system

✍ Furugohri, T.; Sugiyama, N.; Morishima, Y.; Shibano, T. 📂 Article 📅 2011 🏛 Schattauer 🌐 English ⚖ 599 KB

Thrombin, an ideal target for pharmacolo

Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors

✍ Hitinder S. Gurm; Deepak L. Bhatt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 546 KB

Use of Direct Thrombin Inhibitor for Tre

Use of Direct Thrombin Inhibitor for Treatment of Cerebral Venous Thrombosis

✍ Hon, Sonny Fong Kwong; Li, Ho Lun Terrance; Cheng, Pui Wai 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Thrombostatin FM compounds: direct throm

Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo

✍ M. T. NIEMAN; F. BURKE; M. WARNOCK; Y. ZHOU; J. SWEIGART; A. CHEN; D. RICKETTS; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

Biosensor Analysis of Drug–Target Intera

Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors

✍ Robert Karlsson; Mari Kullman-Magnusson; Markku D. Hämäläinen; Annika Remaeus; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 202 KB

The sensitivity of BIACORE technology is sufficient for detection and characterization of binding events involving low-molecular-weight compounds and their immobilized protein targets. The technology requires no labeling and provides information on the stability of the compound/target complex with a